Perrigo shows up downtrodden peers with surprise Q2 generics beat

10th August 2017 Uncategorised 0

Perrigo Thursday delivered something that’s gotten pretty scarce as of late: a generics beat. The company’s branded generics unit delivered $240 million in second-quarter revenue, passing the Street’s $224 million expectations on the back of increased sales of higher-margin products, timing of R&D investments and more.

More: Perrigo shows up downtrodden peers with surprise Q2 generics beat
Source: fierce